MedinCell SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0004065605
EUR
27.56
-1.6 (-5.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
-40.82
-42.29
-13.37
9.13
-15.96
6.24
Shareholder's Funds
-40.82
-42.29
-13.37
9.13
-15.96
6.24
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
56.70
55.16
44.59
42.64
33.05
26.89
Secured Loans
56.70
55.16
44.59
42.64
33.05
26.89
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
-2.48
Other Long Term Liabilities
10.77
2.9
3.18
3.96
5.3
0.5
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
2.27
0.36
0.29
0.26
0.40
0.36
Total Non-Current Liabilities
61.31
14.61
19.43
40.83
36.58
23.97
Current Liabilities
Trade Payables
1.85
4.18
2.98
2.96
3.14
1.64
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
2.27
0.36
0.29
0.26
0.40
0.36
Total Current Liabilities
16.47
57.02
38.24
13.60
6.60
7.77
Total Liabilities
36.95
29.34
44.30
63.61
27.31
37.98
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
10.83
11.00
10.87
6.91
6.31
5.15
Less: Accumulated Depreciation
5.40
4.63
3.84
3.06
2.26
1.83
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
5.43
6.37
7.03
3.85
4.05
3.32
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.44
0.45
0.14
0.77
3.34
4.04
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
1.35
0.99
1.35
1.17
0.67
0.67
Total Non-Current Assets
9.69
9.77
10.23
7.28
9.57
11.96
Current Assets Loans & Advances
Current Investments
5.16
0.00
7.56
6.49
4.34
0.77
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
2.25
2.09
0.80
0.88
0.62
0.38
Cash and Bank
14.30
6.47
19.62
44.09
8.38
21.28
Other Current Assets
26.17
18.74
32.87
55.19
17.11
25.40
Short Term Loans and Advances
4.46
10.18
4.89
3.72
3.77
2.96
Total Current Assets
27.26
19.57
34.07
56.33
17.73
26.02
Net Current Assets (Including Current Investments)
10.79
-37.46
-4.17
42.73
11.13
18.25
Total Current Assets Excluding Current Investments
27.26
19.57
34.07
56.33
17.73
26.02
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
36.95
29.34
44.30
63.61
27.31
37.98
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
56.70
55.16
44.59
42.64
33.05
26.89
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2024 is 331.60% vs -27.94% in Mar 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2024 is 271.38% vs -8.81% in Mar 2023

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2024 is -14.76% vs -9.39% in Mar 2023

stock-summary

Investments

YoY Growth in year ended Mar 2024 is -2.22% vs 221.43% in Mar 2023

stock-summary

Current Assets

YoY Growth in year ended Mar 2024 is 39.29% vs -42.56% in Mar 2023

Compare Balance Sheet Results of MedinCell SA
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
-40.82
8.83
-49.65
-562.29%
Shareholder's Funds
-40.82
8.83
-49.65
-562.29%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
56.70
30.89
25.81
83.55%
Secured Loans
56.70
30.89
25.81
83.55%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
10.77
47.06
-36.29
-77.11%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
2.27
3.00
-0.73
-24.33%
Total Non-Current Liabilities
61.31
69.24
-7.93
-11.45%
Current Liabilities
Trade Payables
1.85
7.92
-6.07
-76.64%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
2.27
3.00
-0.73
-24.33%
Total Current Liabilities
16.47
32.98
-16.51
-50.06%
Total Liabilities
36.95
111.06
-74.11
-66.73%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
10.83
0
10.83
0.00%
Less: Accumulated Depreciation
5.40
0
5.40
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
5.43
5.13
0.30
5.85%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0.44
10.28
-9.84
-95.72%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
1.35
8.04
-6.69
-83.21%
Total Non-Current Assets
9.69
25.32
-15.63
-61.73%
Current Assets Loans & Advances
Current Investments
5.16
14.37
-9.21
-64.09%
Inventories
0
0
0.00
0.00%
Sundry Debtors
2.25
0.65
1.60
246.15%
Cash and Bank
14.30
66.40
-52.10
-78.46%
Other Current Assets
26.17
82.41
-56.24
-68.24%
Short Term Loans and Advances
4.46
0.99
3.47
350.51%
Total Current Assets
27.26
85.74
-58.48
-68.21%
Net Current Assets (Including Current Investments)
10.79
52.76
-41.97
-79.55%
Total Current Assets Excluding Current Investments
27.26
85.74
-58.48
-68.21%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
36.95
111.06
-74.11
-66.73%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
56.70
30.89
25.81
83.55%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 50.54 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is 331.60% vs -27.94% in Mar 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 10.77 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is 271.38% vs -8.81% in Mar 2023

Annual - Fixed Assets
Fixed Assets 5.43 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is -14.76% vs -9.39% in Mar 2023

Annual - Investments
Investments 0.44 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is -2.22% vs 221.43% in Mar 2023

Annual - Current Assets
Current Assets 27.26 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is 39.29% vs -42.56% in Mar 2023